Vivos Therapeutics (VVOS) Consolidated Net Income (2020 - 2026)
Vivos Therapeutics (VVOS) reported Consolidated Net Income of -$7.8 million for Q1 2026, down 100.6% year-over-year from $1.3 billion in Q1 2025, and down 11.46% on a QoQ basis from -$7.0 million in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Consolidated Net Income data on file, last reported at -$7.8 million in Q1 2026.
- Quarterly Consolidated Net Income fell 100.6% year-over-year to -$7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.1 million (down 122.38% YoY) and the FY2025 annual result came in at -$21.2 million, down 89.66% from the prior year.
- Consolidated Net Income fell to -$7.8 million in Q1 2026 per VVOS's latest filing, from -$7.0 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $9.4 million in Q4 2023 and bottomed at -$7.8 million in Q1 2026.
- The 5-year median for Consolidated Net Income is -$5.0 million (2025), against an average of -$3.8 million.
- The widest annual swing landed in 2023, when Consolidated Net Income soared 253.83%; it then plunged 159.74% in 2025.
- Tracing VVOS's Consolidated Net Income over 5 years: stood at -$6.1 million in 2022, then soared by 253.83% to $9.4 million in 2023, then sank by 130.8% to -$2.9 million in 2024, then tumbled by 141.04% to -$7.0 million in 2025, then slipped by 11.46% to -$7.8 million in 2026.
- Per Business Quant, the three latest VVOS Consolidated Net Income figures stand at -$7.8 million (Q1 2026), -$7.0 million (Q4 2025), and -$5.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -7.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.75 Mn |
| Dec 31, 2025 | -6.95 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Jun 30, 2025 | -5.01 Mn |
| Mar 31, 2025 | -3.86 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.62 Mn |
| Jun 30, 2024 | -1.93 Mn |
| Mar 31, 2024 | -3.76 Mn |
| Dec 31, 2023 | -4.26 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -5.53 Mn |
| Mar 31, 2023 | -1.70 Mn |
| Dec 31, 2022 | 17.86 Mn |
| Sep 30, 2022 | -5.43 Mn |
| Jun 30, 2022 | -6.99 Mn |
| Mar 31, 2022 | -5.33 Mn |
| Dec 31, 2021 | 12.91 Mn |
| Sep 30, 2021 | -5.45 Mn |
| Jun 30, 2021 | -4.04 Mn |
| Mar 31, 2021 | -3.40 Mn |
| Dec 31, 2020 | -6.26 Mn |
| Sep 30, 2020 | -1.83 Mn |
| Jun 30, 2020 | -1.44 Mn |
| Mar 31, 2020 | -2.60 Mn |